Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-11-12

FDA Approved: OCTREOTIDE ACETATE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved Sagent Pharmaceuticals' generic octreotide acetate (OCTREOTIDE ACETATE) through an Original Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OCTREOTIDE ACETATE (octreotide acetate)

Snippet

ORIG AP for OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)